UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 233

Sortiert nach

Bimekizumab in psoriatic arthritis: a great leap forward?

The Lancet (British edition), 2023-01, Vol.401 (10370), p.2-3

Queiro, Rubén

2023

Link zum Volltext

Verfügbarkeit prüfen

Psoriatic Arthritis Impact of Disease (PsAID) questionnaire: closer to the all-in-one tool?

Rheumatology (Oxford, England), 2023-11, Vol.62 (11), p.3513-3515

Queiro, Rubén

2023

Link zum Volltext

Verfügbarkeit prüfen

Differentiating facets of quality of life between spondyloarthritis phenotypes: added value of the ASAS health index

Rheumatology (Oxford, England), 2022-07, Vol.61 (7), p.2709-2711

Queiro, Rubén

2022

Link zum Volltext

Verfügbarkeit prüfen

Improvement of Disease Management and Cost Effectiveness in Chinese Patients with Ankylosing Spondylitis Using a Smart-Phone Management System: A Prospective Cohort Study

BioMed research international, 2019-01, Vol.2019, p.2171475-11

2019

Link zum Volltext

Verfügbarkeit prüfen

Analysis of the HAQ-DI components in psoriatic arthritis patients with and without low disease impact

Rheumatology (Oxford, England), 2020-11, Vol.59 (11), p.3569-3570

Queiro, Rubén

2020

Link zum Volltext

Verfügbarkeit prüfen

Cardiometabolic comorbidity in the selection of treatment in spondyloarthritis: one step closer to truly personalized medicine?

Expert opinion on biological therapy, 2021-12, Vol.21 (12), p.1539-1541

Queiro, Rubén

2021

Link zum Volltext

Verfügbarkeit prüfen

Commentary: Sex-based medicine in psoriatic arthritis: Lessons learned from machine learning-based prediction models

Frontiers in immunology, 2022-10, Vol.13, p.1038270-1038270

Queiro, Rubén

2022

Link zum Volltext

Verfügbarkeit prüfen

Remission and stringent treatment goals in psoriatic arthritis: Doctors’ opinion is not enough

Joint, bone, spine : revue du rhumatisme, 2019-03, Vol.86 (2), p.269-270

Queiro, Rubén

2019

Link zum Volltext

Verfügbarkeit prüfen

PsAID High-impact Disease in Psoriatic Arthritis: A Component Weighting Analysis of the Assessment of SpondyloArthritis international Society Health Index

Journal of rheumatology, 2021-12, Vol.48 (12), p.1886

2021

Link zum Volltext

Verfügbarkeit prüfen

In the search for an accurate and early diagnosis of psoriatic arthritis: is the key in ultrasound?

Rheumatology (Oxford, England), 2024-03

2024

Link zum Volltext

Verfügbarkeit prüfen

Family history of disease in spondyloarthritis: a key issue for disease prognosis

Rheumatology (Oxford, England), 2020-10, Vol.59 (10), p.2657-2658

2020

Link zum Volltext

Verfügbarkeit prüfen

The ASAS Health Index: A New Era for Health Impact Assessment in Spondyloarthritis

Journal of rheumatology, 2022-01, Vol.49 (1), p.8

2022

Link zum Volltext

Verfügbarkeit prüfen

Multidisciplinary care for psoriatic disease: Where we are and where we need to go

Rheumatology (Oxford, England), 2017-11, Vol.56 (11), p.1829-1831

2017

Link zum Volltext

Verfügbarkeit prüfen

Does pharmacological intervention prevent or delay the onset of psoriatic arthritis among psoriasis patients?

Expert opinion on biological therapy, 2023-12, Vol.23 (12), p.1159-1162

2023

Link zum Volltext

Verfügbarkeit prüfen

Inflammation-fatigue in spondyloarthritis: a clear link in axial spondyloarthritis but less so in psoriatic arthritis

Rheumatology (Oxford, England), 2021-06, Vol.60 (6), p.3023-3025

2021

Link zum Volltext

Verfügbarkeit prüfen

HLA-C06-defined endotype in psoriatic disease: an ever-widening landscape

Rheumatology (Oxford, England), 2024-03, Vol.63 (3), p.581-583

2024

Link zum Volltext

Verfügbarkeit prüfen

Genetic Variants of the NF-κB Pathway: Unraveling the Genetic Architecture of Psoriatic Disease

International journal of molecular sciences, 2021-11, Vol.22 (23), p.13004

2021

Link zum Volltext

Verfügbarkeit prüfen

HLA-B27 and psoriatic disease: a modern view of an old relationship

Rheumatology (Oxford, England), 2016-02, Vol.55 (2), p.221-229

2016

Link zum Volltext

Verfügbarkeit prüfen

Ultrasound subclinical musculoskeletal findings in inflammatory bowel disease: diagnostic value of positive Doppler signal

Rheumatology (Oxford, England), 2020-11, Vol.59 (11), p.3571-3572

2020

Link zum Volltext

Verfügbarkeit prüfen

Disease impact in axial spondyloarthritis: Divergent roles between family history of disease and HLA-B27?

Reumatología clinica, 2022-12, Vol.18 (10), p.628-629

2022

Link zum Volltext

Verfügbarkeit prüfen

Ustekinumab in psoriatic arthritis: need for studies from real-world evidence

Expert opinion on biological therapy, 2018-09, Vol.18 (9), p.931-935

2018

Link zum Volltext

Verfügbarkeit prüfen

Construct validity of the ASAS health index in psoriatic arthritis: a cross-sectional analysis

Rheumatology (Oxford, England), 2021-03, Vol.60 (3), p.1465-1473

2021

Link zum Volltext

Verfügbarkeit prüfen

Age at disease onset: a key factor for understanding psoriatic disease

Rheumatology (Oxford, England), 2014-07, Vol.53 (7), p.1178-1185

2014

Link zum Volltext

Verfügbarkeit prüfen

Obesity in psoriatic arthritis: Comparative prevalence and associated factors

Medicine (Baltimore), 2019-07, Vol.98 (28), p.e16400-e16400

2019

Link zum Volltext

Verfügbarkeit prüfen

Structural damage is not a major driver of disease impact in patients with long-standing psoriatic arthritis undergoing systemic therapy

Joint, bone, spine : revue du rhumatisme, 2021-03, Vol.88 (2), p.105116-105116, Article 105116

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 233

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(191)
Mit Volltextzugriff
(196)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Bimekizumab in psoriatic arthritis: a great leap forward?

Psoriatic Arthritis Impact of Disease (PsAID) questionnaire: closer to the all-in-one tool?

Differentiating facets of quality of life between spondyloarthritis phenotypes: added value of the ASAS health index

Improvement of Disease Management and Cost Effectiveness in Chinese Patients with Ankylosing Spondylitis Using a Smart-Phone Management System: A Prospective Cohort Study

Analysis of the HAQ-DI components in psoriatic arthritis patients with and without low disease impact

Cardiometabolic comorbidity in the selection of treatment in spondyloarthritis: one step closer to truly personalized medicine?

Commentary: Sex-based medicine in psoriatic arthritis: Lessons learned from machine learning-based prediction models

Remission and stringent treatment goals in psoriatic arthritis: Doctors’ opinion is not enough

PsAID High-impact Disease in Psoriatic Arthritis: A Component Weighting Analysis of the Assessment of SpondyloArthritis international Society Health Index

In the search for an accurate and early diagnosis of psoriatic arthritis: is the key in ultrasound?

Family history of disease in spondyloarthritis: a key issue for disease prognosis

The ASAS Health Index: A New Era for Health Impact Assessment in Spondyloarthritis

Multidisciplinary care for psoriatic disease: Where we are and where we need to go

Does pharmacological intervention prevent or delay the onset of psoriatic arthritis among psoriasis patients?

Inflammation-fatigue in spondyloarthritis: a clear link in axial spondyloarthritis but less so in psoriatic arthritis

HLA-C06-defined endotype in psoriatic disease: an ever-widening landscape

Genetic Variants of the NF-κB Pathway: Unraveling the Genetic Architecture of Psoriatic Disease

HLA-B27 and psoriatic disease: a modern view of an old relationship

Ultrasound subclinical musculoskeletal findings in inflammatory bowel disease: diagnostic value of positive Doppler signal

Disease impact in axial spondyloarthritis: Divergent roles between family history of disease and HLA-B27?

Ustekinumab in psoriatic arthritis: need for studies from real-world evidence

Construct validity of the ASAS health index in psoriatic arthritis: a cross-sectional analysis

Age at disease onset: a key factor for understanding psoriatic disease

Obesity in psoriatic arthritis: Comparative prevalence and associated factors

Structural damage is not a major driver of disease impact in patients with long-standing psoriatic arthritis undergoing systemic therapy

Suchergebnisse filtern